NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
by National Institutes of Health
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional), run by National Institutes of Health, offers non-dilutive federal R&D funding for small businesses. Applications close Apr 5, 2027 · time not confirmed.
Benefits
Non-dilutive federal R&D funding for small businesses
Eligibility
Only United States small business concerns (SBCs), as defined by the Small Business Administration (SBA)(sbir.gov/apply) are eligible to submit applications for this opportunity.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.
Open to: United States
Timeline
- Opens
- May 28, 2026
- Deadline
- Apr 5, 2027 · time not confirmed
- Recurring
- Annual
Questions and answers
When is the deadline for NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)?
The deadline is Apr 5, 2027 · time not confirmed. The organizer does not state a time, so OSH treats it as the end of that day anywhere on Earth.
Who can apply to NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)?
Only United States small business concerns (SBCs), as defined by the Small Business Administration (SBA)(sbir.gov/apply) are eligible to submit applications for this opportunity.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.
What does NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) offer?
Non-dilutive federal R&D funding for small businesses.
Sources
- 1.Grants.gov — May 28, 2026 · Official